HDAC9 and early-onset autosomal dominant Alzheimer disease: Importantly, HDAC inhibition is also extensively discussed as a therapeutic option for other diseases such as cancer [75], Alzheimer’s disease [76], or Duchenne muscular dystrophy [77].